About

Medical isotopes save lives. Through cutting-edge diagnostic technology, isotopes are used to identify internal ailments and allow medical professionals to quickly and accurately treat patients. Previously, the production of these medical isotopes occurred only at a small number of nuclear facilities, which created harmful waste and came with a long list of security and supply concerns.

Canadian Isotope Innovations (CII) is the difference. Using an advanced process, we produce a critical solution to the world’s medical isotope shortage which is clean and reliable. Our proven products help preserve our health, while not compromising the Earth. Additionally, our production and supply is guaranteed; something that current nuclear reactor-based facilities cannot assure.

Our goal at CII is the production of safe, pure medical isotopes produced in a direct and reliable manner. We are the first producer of reactor-free medical isotopes at a commercial scale, providing a solution to a worldwide shortage.

Our dependable product and supply chain allows physicians to help patients with the care they need. Through entrepreneurial innovation and advanced technology, our process is clean, safe, and renewable. Using proven technology, and led by a team of industry experts we provide a clean solution to a critical issue in the radiopharmaceutical industry. We are here to ensure people receive the care they need, without the consequences of fission-based isotope production. Protecting health, while producing safe and pure isotopes reliably.

Career Postings

We are currently seeking to add the following positions to our team:

Our Team

We are a team of dedicated professionals committed to innovating the radiopharmaceutical industry by producing clean, pure medical isotopes without the use of outdated nuclear reactors.

Mark de Jong, CTO of Canadian Isotope Innovations.

Mark de Jong

CTO

Prior to joining CII, Dr. de Jong was the Chief Medical Isotope Officer at Canadian Light Source Inc., heading up the CLS Medical Isotope Project to develop pilot production facility to produce Mo­99 via electron linear accelerators. Before that, he held various positions at Canadian… More...

Kennedy Mang’era, COO of Canadian Isotope Innovations.

Kennedy Mang’era

COO

Prior to his role as COO of CIIC, Dr. Mang’era was Director of the WRHA Central Radiopharmacy in Winnipeg for over 8 yrs. As Technical Scientific Leader at the consortium the Prairie Isotope Production Enterprise (PIPE) and Head of the Radiopharmaceuticals Research Group at the WRHA, he… More...

Doug Ullrich, VP Engineering of Canadian Isotope Innovations.

Doug Ullrich

VP Engineering

Doug Ullrich is a mechanical engineer with specialization in the nuclear industry. He graduated from the University of Alberta in 1990 with a BSc. in Mechanical Engineering and is a professional engineer registered with the Association of Professional Engineers and Geoscientists of… More...

James dela Cruz, Engineering Physicist/Analyst of Canadian Isotope Innovations.

James dela Cruz

Engineering Physicist/Analyst

James dela Cruz graduated with a B.Eng. in Engineering Physics from the University of Saskatchewan in 2014 and has continued his education in courses Accelerators for Medical Applications organized by the CERN Accelerator School in Europe. He began working at the Canadian Light Source… More...

Jeremy A. Olson, Chemist of Canadian Isotope Innovations.

Jeremy A. Olson

Chemist

Prior to joining CII, Jeremy worked in the Industrial Science group at Canadian Light Source Inc., where he worked with Industry partners to help them solve their problems using various synchrotron x-ray techniques such as CT, XRD and Spectroscopy. He has been involved in developing… More...

Hao Zhang, Lead Engineer, Operation & Control Systems of Canadian Isotope Innovations.

Hao Zhang

Lead Engineer, Operation & Control Systems

Hao Zhang received his Bachelor’s degree in Industrial Automation from Northwestern Polytechnical University in China ​in 1995, and a Masters of Applied Science in Electronic System Engineering from the University of Regina in 2004. Hao is a professional engineer registered with the… More...

Lidia Matei, Chemist-Regulatory Affairs Manager of Canadian Isotope Innovations.

Lidia Matei

Chemist-Regulatory Affairs Manager

With over 10 years of experience in radiochemistry research and production of radiopharmaceuticals, Dr. Matei makes a great addition to the CII team. Prior to joining our team, Dr. Matei acted as a Radiochemist in the field of cyclotron produced radioisotopes. During her tenure at Best… More...

Our Partners

Canadian Light Source

Canadian Light Source

The Canadian Light Source is a national research facility, one of the largest science projects in our country’s history, and the brightest light in Canada—millions of times brighter than even the sun—used by scientists from around the world in ground-breaking health, environmental,… More...